Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
Plos One
|
August 10, 2016
Dendritic Cells from HIV Controllers Have Low Susceptibility to HIV-1 Infection In Vitro but High Capacity to Capture HIV-1 Particles
Chiraz Hamimi, Annie David, Pierre Versmisse, et al.
The Journal of Antimicrobial Chemotherapy
|
December 18, 2015
Drug resistance and tropism as markers of the dynamics of HIV-1 DNA quasispecies in blood cells of heavily pretreated patients who achieved sustained virological suppression
Pierre Gantner, Laurence Morand-Joubert, Charlotte Sueur, et al.
The Journal of Antimicrobial Chemotherapy
|
April 23, 2015
Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission
Antoine Chéret, Charline Bacchus-Souffan, Veronique Avettand-Fenoël, et al.
AIDS (London, England)
|
May 30, 2024
Low cabotegravir trough concentrations without oral lead-in in patients with HIV-1 switching to long-acting cabotegravir and rilpivirine
Emma Rubenstein, Myriam Diemer, Lauriane Goldwirt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 21, 2014
Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial
Laurent Cotte, Joséphine Braun, Caroline Lascoux-Combe, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
March 15, 2024
High proportion of post-migration HIV acquisition in migrant men who have sex with men receiving HIV care in the Paris region, and associations with social disadvantage and sexual behaviours: results of the ANRS-MIE GANYMEDE study, France, 2021 to 2022
Romain Palich, Andrés Arias-Rodríguez, Martin Duracinsky, et al.
Plos One
|
May 22, 2013
A single HIV-1 cluster and a skewed immune homeostasis drive the early spread of HIV among resting CD4+ cell subsets within one month post-infection
Charline Bacchus, Antoine Cheret, Véronique Avettand-Fenoël, et al.
European Journal of Gastroenterology & Hepatology
|
April 30, 2019
Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort
Mathieu Chalouni, Philippe Sogni, Patrick Miailhes, et al.
The Lancet. Infectious Diseases
|
February 22, 2015
Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial
Antoine Chéret, Georges Nembot, Adeline Mélard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 19, 2016
All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort
Philippe Sogni, Camille Gilbert, Karine Lacombe, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
Plos One
|
August 10, 2016
Dendritic Cells from HIV Controllers Have Low Susceptibility to HIV-1 Infection In Vitro but High Capacity to Capture HIV-1 Particles
Chiraz Hamimi, Annie David, Pierre Versmisse, et al.
The Journal of Antimicrobial Chemotherapy
|
December 18, 2015
Drug resistance and tropism as markers of the dynamics of HIV-1 DNA quasispecies in blood cells of heavily pretreated patients who achieved sustained virological suppression
Pierre Gantner, Laurence Morand-Joubert, Charlotte Sueur, et al.
The Journal of Antimicrobial Chemotherapy
|
April 23, 2015
Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission
Antoine Chéret, Charline Bacchus-Souffan, Veronique Avettand-Fenoël, et al.
AIDS (London, England)
|
May 30, 2024
Low cabotegravir trough concentrations without oral lead-in in patients with HIV-1 switching to long-acting cabotegravir and rilpivirine
Emma Rubenstein, Myriam Diemer, Lauriane Goldwirt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 21, 2014
Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trial
Laurent Cotte, Joséphine Braun, Caroline Lascoux-Combe, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
March 15, 2024
High proportion of post-migration HIV acquisition in migrant men who have sex with men receiving HIV care in the Paris region, and associations with social disadvantage and sexual behaviours: results of the ANRS-MIE GANYMEDE study, France, 2021 to 2022
Romain Palich, Andrés Arias-Rodríguez, Martin Duracinsky, et al.
Plos One
|
May 22, 2013
A single HIV-1 cluster and a skewed immune homeostasis drive the early spread of HIV among resting CD4+ cell subsets within one month post-infection
Charline Bacchus, Antoine Cheret, Véronique Avettand-Fenoël, et al.
European Journal of Gastroenterology & Hepatology
|
April 30, 2019
Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort
Mathieu Chalouni, Philippe Sogni, Patrick Miailhes, et al.
The Lancet. Infectious Diseases
|
February 22, 2015
Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial
Antoine Chéret, Georges Nembot, Adeline Mélard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 19, 2016
All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus-coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13-HEPAVIH Cohort
Philippe Sogni, Camille Gilbert, Karine Lacombe, et al.
Page
of 8